Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications
Cells · 28.02.2025 · 14 (5) · 353
DOI: 10.3390/cells14050353 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 28.02.2025. Verfasst von Tommaso Bucci und 6 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool and Heart and Chest Hospital, Li…. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Thrombosis, Fibrinolytic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The thrombotic physiopathology of antiphospholipid syndrome (APS) is complex, heterogeneous, and dynamic. While venous thromboembolism (VTE) is the most common initial presentation, arterial thrombotic events (ATE) become more frequent in advanced stages and are associated with high morbidity and mortality. Despite the use of oral anticoagulants (OACs), thrombotic APS remains associated with a high risk of recurrent thrombosis. Given their potential antithrombotic effects capable of reducing the risk of both VTE and ATE, statins have been proposed as an adjunctive therapy to OACs for patients with APS and recurrent thrombosis. However, this recommendation is primarily based on studies not specifically conducted in APS populations, with only preclinical data or evidence from retrospective observational studies available from APS patients cohorts. For these reasons, this narrative review aims to synthesise the studies evaluating the potential antithrombotic effects of statins in patients with APS, highlighting the progress made and identifying areas for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool and Heart and Chest Hospital, Liverpool, L7 8TX, UK.
- Department of Clinical Internal, Anaesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, Italy.
- Department of General and Specialized Surgery "Paride Stefanini", Sapienza University of Rome, 00185 Rome, Italy.
- IRCCS Neuromed, Località Camerelle, 86077 Pozzilli, Italy.
- Immune Response and Vascular Disease, iNOVA, 4Health, Nova Medical School, Nova University Lisbon, 1099-085 Lisbon, Portugal.
- Department of Haematology, Dumfries Royal Infirmary, Cargenbridge, Dumfries DG2 8RX, UK.
ORCID-Profile: Tommaso Bucci, Danilo Menichelli, Daniele Pastori, Gregory Y H Lip, Pasquale Pignatelli
Zitieren
APA
Bucci, T., Menichelli, D., Palumbo, I. M., Pastori, D., Ames, P. R. J., Lip, G. Y. H., & Pignatelli, P. (2025). Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications. Cells, 14(5), 353. https://doi.org/10.3390/cells14050353
Vancouver
Bucci T, Menichelli D, Palumbo IM, Pastori D, Ames PRJ, Lip GYH, et al. Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications. Cells. 2025;14(5):353. doi:10.3390/cells14050353
BibTeX
@article{Bucci2025,
author = {Bucci, Tommaso and Menichelli, Danilo and Palumbo, Ilaria Maria and Pastori, Daniele and Ames, Paul R J and Lip, Gregory Y H and Pignatelli, Pasquale},
title = {Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications},
journal = {Cells},
year = {2025},
volume = {14},
number = {5},
pages = {353},
doi = {10.3390/cells14050353}
}
EUVIMED